The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 has been up 0.5% at 8,582 points.

The Aussie index pared early gains as speculation continues to swirl around the RBA’s rate decision, which is due in next week after a Monday-Tuesday meeting.

IT and Staples have been the best-performing sectors, up 1.5%, followed by Utilities, up 1.35%, and Discretionary, up 1%.

Health Care has been the worst performer, down 0.33%.

Company News

Imugene (ASX:IMU) has been up 7.7% following the release of a trial update. The company revealed more positive results, and the market reacted positively.

Imugene has been 4.2 cents.

AVITA Medical (ASX:AVH) has been up 10.1% after posting its quarterlies. The company achieved commercial revenue of $18.4 million in Q4, marking a 30% increase from the same period last year.

Avita Medical has been $3.04.

AMP (ASX:AMP) has been down 14.8% after reporting a 15.1% year-on-year increase in NPAT to $236 million.

AMP has been $1.49.

Join the discussion: See what’s trending right now on Australia’s largest stock forum and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

More From The Market Online
Market concept

(Last) Market Close (of 2025): October back again as DRO, EOS & 4DX pop; otherwise mid day

If you wanted to feel like you were re-living the festivity season for the XJO that was October, look no further than today’s

EV Resources on ‘accelerated pathway’ to Los Lirios restart after strong antimony recovery tests

EV Resources is inching closer to a Los Lirios restart after strong metallurgical results set up…
Magneto scan concept

MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY

Compumedics, a biotech company developing its Orion Lifespan MEG product, could just be the next big…

Coles, Woolies left furious over gov’t checks designed to limit ‘excessive pricing on groceries’

Coles and Woolworths have come out swinging against the government's plan to impose stricter rules to…